news
N.F. Gamaleya Center and Petrovax Pharm join forces to advance innovative medicines
The National Research Center for Epidemiology and Microbiology named after N.F. Gamaleya of the Ministry of Health of the Russian Federation and the biopharmaceutical company Petrovax Pharm have signed a strategic cooperation agreement. The partnership is aimed at developing and producing novel pharmaceuticals to combat cancer, orphan, and infectious diseases. The cooperation will focus on substance manufacturing technology transfer projects.
Russia launches program to help breast cancer patients get innovative drug pyrotinib
Petrovax Pharm's revenue increased by 43% in 2024
Petrovax Pharm gets new director for its production complex
First patient with Fabry disease starts treatment with entirely Russian product
Specialists gathered at a conference in Kazan to discuss successful ARVI and influenza control methods
Leading experts recommend including new drug camrelizumab in Clinical Guidelines for esophageal cancer
RUSSCO includes Areima® in the most preferred first-line regimen of nasopharyngeal cancer therapy
Happy New Year 2025!
